Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta

被引：5
作者：
Gibbs, E. [1 ]
Tremlett, H. [1 ]
Ball, N. [2 ]
Hashimoto, S. [1 ]
机构：
[1] Univ British Columbia, Fac Med, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol, Vancouver, BC V6T 2B5, Canada
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷 / 01期
关键词：
interferon beta; melanoma; multiple sclerosis; neutralizing antibodies;
D O I：
10.1111/j.1468-1331.2007.01989.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E4 / E4
页数：1
相关论文
共 7 条
  • [1] CARMICHAEL VE, 1992, CAN J SURG, V35, P589
  • [2] Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821
  • [3] DUQUETTE P, 1995, NEUROLOGY, V45, P1277
  • [4] Francis G, 2001, NEUROLOGY, V56, P1628
  • [5] Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
    Kleinschmidt-DeMasters, BK
    Tyler, KL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) : 369 - 374
  • [6] Randomized, comparative study of interferon β-1a treatment regimens in MS -: The EVIDENCE trial
    Panitch, H
    Goodin, DS
    Francis, G
    Chang, P
    Coyle, PK
    O'Connor, P
    Monaghan, E
    Li, D
    Weinshenker, B
    [J]. NEUROLOGY, 2002, 59 (10) : 1496 - 1506
  • [7] Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005
1